VIAV VIAVI SOLUTIONS INC.
Semiconductors & Related Devices · Nasdaq · SEC CIK 912093 · Fiscal year ends 06/27
Financial factors as of 2026-10-03 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY47.4%
TTM net income YoY340.8%
TTM EPS YoY333.3%
Revenue 3-yr CAGR17.4%
Net income 3-yr CAGR191.7%
Margins
Gross margin58.9%
Operating margin10.6%
Net margin4.0%
FCF margin9.1%
EBITDA margin13.0%
Returns
ROE6.5%
ROA2.9%
ROIC (approx.)9.2%
Asset turnover0.72x
Leverage & solvency
Liabilities / assets48.8%
Debt / equity0.49x
Current ratio1.65x
Interest coverage3.92x
Cash quality & payout
Operating cash flow / net income2.80x
Accruals ratio-5.2%
Payout ratio—
Capex / revenue2.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-27 | FY20252025-06-28 |
|---|---|---|
| Income statement | ||
| Revenue | $1.52B | $1.08B |
| Cost of revenue | $642.90M | $463.20M |
| Gross profit | $875.40M | $621.10M |
| R&D expense | $262.70M | $208.70M |
| SG&A expense | $469.20M | $349.40M |
| Operating income | $105.10M | $57.50M |
| Interest expense | $47.40M | $30.00M |
| Pretax income | $16.30M | $38.60M |
| Income tax | $47.50M | $4.40M |
| Net income | -$30.40M | $34.80M |
| EBITDA | $145.50M | $95.90M |
| EPS (basic) | -0.13 | 0.16 |
| EPS (diluted) | -0.13 | 0.15 |
| Weighted avg. shares (diluted) | 229.50M | 225.70M |
| Balance sheet | ||
| Cash & equivalents | $647.80M | $432.10M |
| Short-term investments | $2.00M | $1.70M |
| Receivables | $351.30M | $261.00M |
| Inventory | $155.30M | $117.90M |
| Current assets | $1.26B | $885.20M |
| PP&E, net | $224.50M | $231.90M |
| Goodwill | $700.70M | $595.70M |
| Intangibles | $377.60M | $131.60M |
| Total assets | $2.71B | $1.99B |
| Current liabilities | $680.50M | $589.70M |
| Short-term debt | $244.80M | $246.20M |
| Long-term debt | $397.10M | $396.30M |
| Total debt | $641.90M | $642.50M |
| Total liabilities | $1.26B | $1.21B |
| Shareholders' equity | $1.45B | $780.20M |
| Net debt | -$5.90M | $210.40M |
| Shares outstanding | 247.00M | 223.00M |
| Cash flow statement | ||
| Operating cash flow | $113.90M | $89.80M |
| Capital expenditure | $31.10M | $27.80M |
| Free cash flow | $82.80M | $62.00M |
| Investing cash flow | -$426.80M | -$128.40M |
| Financing cash flow | $541.00M | -$23.60M |
| Depreciation & amortization | $40.40M | $38.40M |
| Stock-based compensation | $55.40M | $53.10M |
| Share buybacks | $30.00M | $16.40M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.